Medicare Granted NTAP to Viz.ai

The key shift was that Viz turned stroke triage software from a hospital IT purchase into a reimbursable clinical intervention. Medicare paid for it through NTAP, which is the add on payment CMS uses when a new technology improves care but is not yet covered by the normal DRG bundle. That mattered because stroke teams could now justify buying software not as overhead, but as a tool tied directly to inpatient revenue and faster thrombectomy workflows.1 2 3 4

• Viz was the first AI software to win this pathway. Medicare granted NTAP for Viz in 2020, and radiology policy literature described it as the first time Medicare created inpatient payment for AI software. That gave later imaging AI vendors a template to follow, including other stroke triage products.2 4 5
• The pathway sat inside inpatient hospital reimbursement, not physician billing. Hospitals already receive a fixed DRG payment for a stroke admission. NTAP adds extra payment only when CMS decides the technology is new, costly relative to the DRG, and improves outcomes enough to deserve separate support.3 4 6
• Viz also broadened the playbook from one LVO product to a family of reimbursable neuro tools. CMS tracking forms later show Viz filing NTAP applications for Viz STROKE NCCT and Viz SDH, with the software combining image detection, secure team messaging, and mobile image viewing into one acute care workflow.1 6

This points toward medical AI being bought less like analytics software and more like procedure enabling infrastructure. The winners will be products that move a patient into treatment faster, fit inside hospital billing rules, and then expand from one emergency condition into adjacent high acuity workflows using the same care coordination layer.1 2 4 5